Fig. 3: Characterization of SLFN11 phosphomimetic mutants S219D, T230D, and S753D.
From: Phosphorylation-mediated conformational change regulates human SLFN11

a Positions of phosphorylation sites S219 and T230 (purple) in the nuclease domains of SLFN11wt bound to tRNA-Leu. The nuclease active sites of both SLFN11wt protomers are indicated. b Position of phosphorylation site S753 (purple) in the ssDNA-bound helicase domain of SLFN11wt (PDB: 7ZES). c MST measurements of SLFN11wt and phosphomimetic mutants (S219D, T230D, S753D) binding to fluorescently labeled type II tRNA-Leu to determine equilibrium dissociation constants (Kd). The indicated SLFN11 concentrations assume a dimeric state. Data are represented as mean values +/− SD from three independent experiments. d Analysis of tRNA-Leu cleavage by SLFN11wt, SLFN11S219D, SLFN11T230D, and SLFN11S753D. Data are represented as mean values +/− SD from three independent experiments. e NanoDSF measurements of SLFN11S753D (left) and SLFN11wt (right) in the presence of ssDNA and dsDNA. Data are represented as mean values +/− SD from three independent experiments. One representative replicate is shown. f ssDNA binding of SLFN11wt and SLFN11S753D (left), as well as SLFN11S219D and SLFN11T230D (right) monitored by electrophoretic mobility shift assays. The experiment was performed in duplicates. One representative replicate is shown. Source data for c–f are provided as a Source Data file.